Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05178888
Title Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 804 Orlando Florida 32827 United States Details
Local Institution - 803 Nashville Tennessee 37203 United States Details
Local Institution - 802 Houston Texas 77030 United States Details
NEXT Oncology - NEXT San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field